first edition (1980) of the Orange Book - FDA Law Blog

More documents

Recommendations

Info

APPROVED PRESCRIPTION DRUG PRODUCTSDRUG PRODUCT LIST84MESORIDAZINE BESYLATEMESTRANOL; NORETHYNODRELINJECTABLE; INJECTIONSERENTILSANDOZ PH ARMSEQ 2SMG BASE/MLTABLET; ORALENOVIDSEARLE7S UGM;5MG * ISO UGM;9.8SMGTABLET; ORALSERENTILSANDOZ PH ARMSEQ 10MG BASE * EQ 2SMG BASE *EQ SOMG BASE * EQ 100MG BASETABLET; ORAL-20ENOVIDSEARLEENOVID-ESEARLE7S UGM;SMG100 UGM;2.SMGMESTRANOL; *MULTIPLE*SEE ETHYNODIOL DIACETATE; MESTRANOLTABLET; ORAL-21ENOVID-E 21SEARLE100 UGM;2.SMGA8ABABABABABABAB.MESTRANOL; NORETHINDRONETABLET; ORAL-20NORINYLSYNTEX(F PITABLET; ORAL-21HORl:HYL 1+50 21SYNTEX(F PIHOR:IHYL 1+80 ZlSYNTEX(F PIORTHO-H~VUM 1/50 21ORTHO PHARMORTHO-HOVUM 1/80 21ORTHO PHARMORTHO-NOVUM 10-21ORTHO PHARMORTHO-NOVUM 2-21ORTHO PHARMTABLET; ORAL-28HOR:IHYL 1+50 28SYNTEX(F PIHOR:IHYL 1+80 28SYNTEX(F PIORTHO-HOVUM 1/50 28ORTHO PHARMORTHO-HOVUM 1/80 28ORTHO PHARM100 UGM;2MG~;lMG~;lMG50 UGM;lMG80 UGM;lMG60 UGM;lOMG100 UGM;2MG~;lMG~;lMGSO UGM;lMG~;lMGAPAPAPAPAPAPMETAPROTERENOL SULFATEAEROSOL; INHALATIONALUPENTBOEHRINGER INGELHEIM lSMG/MLSYRUP; ORALALUPENTBOEHRINGER INGELHEIM 10MG/SMLTABLET; ORALALUPENTBOEHRINGER INGELHEIM 10MG * 20MGMETARAMINOL BITARTRATEINJECTABLE; INJECTIONAR.AM:IHEMERCK SHARP & DOHMEMETARAM:IHOL B:ITARTRATEAM MCGAW/AM HOSP. BRISTOL LABS/BMELKINS-SINN/AHROBINSINT'L MEDICATION SYSINVENEX PHARMS/MOGULEQ 10MG BASE/MLEQ 100MG 8ASE/I0MLEQ 200MG BASE/I0MLEQ 10MG BASE/MLEQ 10MG BASE/MLEQ 10MG BASE/MLEQ lONG BASE/ML
APPROVED PRESCRIPTION DRUG PRODUCTSDRUG PRODUCT LIST85METAXAlONETABLET; ORALSKElAXINAH ROBINSIMETHACYClINE HYDROCHLORIDECAPSULE; ORALRONDOMYCINWAllACE lABS/C-WSYRUP; ORALRONDOMYCINWAllACE LABS/C-WMETHADONE HYDROCHLORIDECONCENTRATE; ORALMETHADOSEMAllINCKRODTINJECTABLE; INJECTIONDOlOPHIN,E HClEll lILLYSYRUP; ORALDOLOPHrHE HCLAA ELI lILLYWESTADOHEAA VITARINE/WEST CHEMTABLET; ORALDOlOPHINE HClEll lILLYMETHADONE HClELI lILLY400"MGEQ 140NG BASE * EQ 280MG BASEEQ 70MG BASE/SMLlOMGIMLlOMG/ML10MGI'30ML10MG/30ML20MG/30Ml * 30MG/30Ml * 40MG/30Ml *SOHG/30Ml * 60MG/30Ml * 70MG/30Ml *80MG/30Ml * 90MG/30Ml * lOOMG/30Ml5HG * lONG40MGTABLET, EFFERVESCENT; ORALWESTADONEVITARINE/WEST CHEM 2.5MG * 5MG * lOMG * 40MGMETHAMPHETAMINE HYDROCHLORIDETABLET; ORALDESOXYHAA ABBOTT lABS 5MB2.5MGMETHAMPEXAA lEMMON PHARMACAL 10MBMETHAMPHETAMrHE HClAA REXAR PHARMACAL 5MB IE .!.9.M§TABLET, CONTROllED RELEASE; ORALDESOXYNABBOTT lABSMETHANTHELINE BROMIDEINJECTABLE; INJECTIONBANTHINESEARLETABLET; ORALBANTHINESEARLEMETHAQUALONETABLET; ORALQUAALUDEA8 LEMNON PHARMACALSOPORBP ARNAR-STONE lABSMETHAqUALONE HYDROCHLORIDECAPSULE; ORALPAREST-200PARKE-DAVIS/W-LPAREST-400PARKE-DAVIS/W-l5MG * lOMG * 15MGSOMGI'VIAL50MG150MB • 500MG150MG * 300HG75MGEQ 175MG BASEEQ 350MG BASE
Page 5:
RXD AND DRUG ACMINISTRATIONAPProVED
Page 9:
approved application, a list of app
Page 12 and 13:
products that have been approved" i
Page 14 and 15:
To assist the user in relating the
Page 16 and 17:
an evaluatien of therapeutic equiva
Page 18 and 19:
ioavailability data is required for
Page 20 and 21:
B - Drug products that FDA does not
Page 22 and 23:
and the rate of absorption.pharmace
Page 24 and 25:
4. Erythromycin stearate Tablets -
Page 27 and 28:
II. LISTINGSA. FORMAT GUIDEThis p..
Page 29 and 30:
CURRENT STATUS - POSSIBLY EFFECTIVE
Page 31 and 32:
DRUG ProDUCT EKAMPLESSingle Ingredi
Page 33 and 34:
APPROVED PRESCRIPTION DRUG PRODUCTS
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
j./APPROVED PRESCRIPTION DRUG PRODU
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66: -,----APPROVED PRESCRIPTION DRUG PR
Page 67 and 68: APPROVED PRESCRI~TIOHDRUG PRODUCTSD
Page 69 and 70: APPROVED PRESCRIPTION DRUG PRODUCTS
Page 77 and 78: DIMENHYDlHNATEAPPROVED PRESCRIPTION
Page 81 and 82: ------"".,APPROVED PRESCRIPTION DRU
Page 91 and 92: APPROVED ¥RESCRIPTION DRUG PRODUCT
Page 95 and 96: '''"APPROVED PRESCRIPTION DRUG PROD
Page 97 and 98: ----..//APPROVED PRESCRIPTION DRUG
Page 115: APPROVED PRESCRIPTION DRUG PRODUCTS
Page 125 and 126: "~''''''-- .APPROVED PRESCRIPTION D
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
PERCORTEN PIVALATE, DESOXYCORTICOST
Page 191 and 192:
Page 193 and 194:
Page 195:
oAPPROVED PRESCRIPTION DRUG PRODUCT
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
APPROVED PRESCRIPTIOH DRUG PRODUCTS
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243:
Page 246 and 247:
PRESCRIPTION DRUG PRODUCTS DEEMED A
Page 248 and 249:
Page 250 and 251:
show all

first edition (1980) of the Orange Book - FDA Law Blog

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?